ArticleMolecular cancer2026

ROCK1 inhibition primes anti-tumor immunity in EGFR-mutant NSCLC by triggering PD-L1 degradation mediated by SMURF2.

Menglin Bai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.